Sudoscan in Patients With Autoimmune Disorders
NCT02434458 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85
Last updated 2015-09-15
Summary
The purpose of this study is to assess the diagnostic utility of Sudoscan in assessing small fiber nerve function, specifically those of the sudomotor, in patients with autoimmune disorders (i.e fibromyalgia and rheumatoid arthritis).
Conditions
Sponsors & Collaborators
-
The Catholic University of Korea
lead OTHER
Principal Investigators
-
Su-Jin Monn, M.D., PhD · Catholic University of Korea, College of Medicine Bucheon St. Mary's Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-05-31
- Primary Completion
- 2015-09-30
- Completion
- 2015-09-30
Countries
- South Korea
Study Locations
More Related Trials
-
TNFα Monoclonal Antibody for Acute Spinal Cord Injury
NCT04988425 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Rituximab in Chronic Inflammatory Demyelinating Polyneuropathy
NCT04480450 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)
NCT04281472 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Diagnostic Contributions of Nerve Ultrasound in Chronic Inflammatory Demyelinating Polyneuropathy Associating Systemic Diseases (CIDP Echo-nerf)
NCT05257733 ·Status: WITHDRAWN
-
Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT07154524 ·Status: RECRUITING
-
Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
NCT01017159 ·Status: COMPLETED ·Phase: PHASE2
-
Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices
NCT07273903 ·Status: RECRUITING
-
Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT02465359 ·Status: COMPLETED ·Phase: NA
-
Intravenous Immunoglobulin Therapy for Small Fiber Neuropathy
NCT02637700 ·Status: COMPLETED ·Phase: PHASE2
-
IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements
NCT02414490 ·Status: COMPLETED
-
Sensitivity of Repetitive Nerve Stimulation Performed in the Evening vs in the Morning in Myasthenia Gravis
NCT05337891 ·Status: RECRUITING
-
Biomarkers in Autoimmune Disease of Nervous System
NCT06502015 ·Status: RECRUITING
-
Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy
NCT05833711 ·Status: UNKNOWN ·Phase: PHASE2
-
Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT04881682 ·Status: RECRUITING ·Phase: PHASE2
-
Markers of Favorable Response to FcRn Inhibitors(INFORM)
NCT06685055 ·Status: RECRUITING
-
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
NCT06455449 ·Status: RECRUITING ·Phase: PHASE3
-
A Switch-Over Study of the Safety and Efficacy of ISU302 in Patients With Type 1 Gaucher Disease
NCT02053896 ·Status: COMPLETED
-
Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis
NCT05986162 ·Status: UNKNOWN ·Phase: PHASE1
-
Markers of Favorable Response to Complement Inhibitors Therapy
NCT06455709 ·Status: RECRUITING
-
Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS)
NCT01420432 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of Rituxan in the Treatment of Polyneuropathies Associated With Serum IgM Autoantibodies
NCT00006072 ·Status: UNKNOWN ·Phase: PHASE2
-
Immune Abnormalities in Sporadic Inclusion Body Myositis
NCT00030212 ·Status: COMPLETED
-
Biomarkers in Polyradiculoneuropathies
NCT04249752 ·Status: UNKNOWN
-
Peripherical Neuromuscular Electrical Stimulation in Systemic Autoimmune Myopathies
NCT03751644 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
NCT04561557 ·Status: RECRUITING ·Phase: EARLY_PHASE1